Plasma-based proteomics analysis of molecular pathways in canine diabetes mellitus after astaxanthin supplementation
Open Access
- 7 May 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0321509
Abstract
The hyperglycemic state in diabetes mellitus induces oxidative stress and inflammation, contributing to diabetic tissue damage and associated complications. Astaxanthin, a potent antioxidant carotenoid, has been investigated for its potential to prevent and manage diabetes across various species; however, its effect on client-owned dogs remains poorly studied. This study explored the impact of astaxanthin supplementation on canine diabetes mellitus using a proteomics approach. A total of 18 client-owned dogs were enrolled: 6 dogs with diabetes mellitus and 12 clinically healthy dogs. The diabetic dogs received their standard treatment regimen along with daily oral supplementation of 12 mg of astaxanthin (1.5–2.4 mg/kg) for 90 days. Plasma samples were collected at the beginning and end of the study period for proteomics analysis. After astaxanthin supplementation, significant alterations in the expression of proteins associated with the complement system, coagulation cascade, JAK–STAT signaling, and protein kinase C signaling (all of which contribute to inflammation and oxidative stress) were observed. Astaxanthin exhibited potential for reducing diabetes-associated complications, such as insulin resistance, vascular dysfunction, nephropathy, and cardiac issues, even though it did not affect clinical parameters (hematology, plasma biochemistry, blood glucose, and serum fructosamine). These findings suggest that astaxanthin may be a valuable complementary therapy for managing diabetes-related complications in canines.Keywords
Funding Information
- Agricultural Research Development Agency (CRP6305031600)
- Agricultural Research Development Agency (PRP6605030100)
This publication has 110 references indexed in Scilit:
- NF‐κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammationCell Biochemistry and Function, 2024
- Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective reviewMolecular and Cellular Biochemistry, 2022
- Complement in metabolic disease: metaflammation and a two-edged swordSeminars in Immunopathology, 2021
- Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to CorrectionBulletin of Experimental Biology and Medicine, 2021
- Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemiaDiabetologia, 2020
- Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complicationsDARU Journal of Pharmaceutical Sciences, 2020
- The molecular details of cytokine signaling via the JAK/STAT pathwayProtein Science, 2018
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001
- Soluble interleukin-2 receptor level in serum of children with insulin-dependent diabetes mellitus compared with that in diseases with activated immune systemPathophysiology, 1996
- Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospectsDiabetologia, 1993